342 related articles for article (PubMed ID: 17511031)
21. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
22. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
23. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
[TBL] [Abstract][Full Text] [Related]
24. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.
Wei W; Wang SF; Yu B; Ni M
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):828-832. PubMed ID: 29270739
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
28. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
Cui X; Inagaki Y; Xu H; Wang D; Qi F; Kokudo N; Fang D; Tang W
Biol Pharm Bull; 2010; 33(10):1728-32. PubMed ID: 20930383
[TBL] [Abstract][Full Text] [Related]
29. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
30. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
32. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
33. [Specific small interfering RNAs inhibit replication of hepatitis B virus].
Jiao J; Cao H; Zhou MJ; Liu ZH; Ding ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):465-7. PubMed ID: 17545032
[TBL] [Abstract][Full Text] [Related]
34. [Inhibition of HBsAg and HBeAg secretion by RNA interference of the polymerase gene sequence of hepatitis B virus: an experimental study].
Liu SA; Wei HS; Dong QM; Guo JJ; Qin J; Zhang QY; Liu ZY; Yan J; Cheng J
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3079-83. PubMed ID: 16324412
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
Melegari M; Scaglioni PP; Wands JR
Hepatology; 1998 Feb; 27(2):628-33. PubMed ID: 9462667
[TBL] [Abstract][Full Text] [Related]
36. Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro.
Wu L; Wang W; Zhang X; Zhao X; Yu G
Carbohydr Polym; 2016 Jun; 143():139-48. PubMed ID: 27083353
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
38. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
39. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
40. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]